Skip to main content
Premium Trial:

Request an Annual Quote

Angle: Todd Druley

Angle has appointed Todd Druley as its chief medical officer. Druley previously served as chief medical officer at ArcherDx, where he oversaw the establishment of new translational applications for that company's assays, including its patient-specific Personalized Cancer Monitoring assay. Druley taught for 15 years at Washington University, where he published over 60 peer-reviewed and invited manuscripts. His clinical focus is leukemia, and Druley has patented and licensed various technologies for error-corrected next-generation sequencing for quantitative clonal hematopoiesis and molecular residual disease detection. 

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.